| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |